Kalm Therapeutics (Kalm Tx) is pleased to announce the appointment of Dr. Tomoko Maeda-Chubachi, M.D., Ph.D., as our Chief ...

IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of ...

More than 39 million people around the world could die from antibiotic-resistant infections over the next 25 years, according to a study published in The Lancet.  The new study by the Global Research ...

Invasive meningococcal disease (IMD) is rare and most people survive.1 However, even with appropriate medical care, up to 1 in 10 patients who ...

With Prince Harry set to make his way to the UK in less than two weeks, his father King Charles is allegedly not thrilled ...

The Allergy & Clinical Immunology Society (ACIS) of Nigeria in association with Emerging Societies Program (ESP) is set to optimise allergy care at the first ever ...

AFL legend and current Swans CEO Tom Harley, and his podcaster wife Felicity said they “did not know enough” about ...

Fidson, which is listed in Lagos where its stock has shed 24.6 per cent this year, is valued at N30.3 billion.

at 15:20 Kirby McInerney LLP Reminds ZoomInfo Technologies Inc. (ZI) Investors of Class Action Filing and Encourages Investors to Contact the Firm The law firm of Kirby McInerney LLP reminds investors ...

British drugmaker GSK said on Wednesday administration of its respiratory syncytial virus (RSV) vaccine and shingles shot ...

Bank of America Securities analyst Graham Parry maintained a Sell rating on GlaxoSmithKline (GSK – Research Report) yesterday and set a ...